Suppr超能文献

潜在大麻素受体 GPR55 的脂衍生激动剂的脂质双层分子动力学研究。

Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55.

机构信息

Center for Drug Discovery, Department of Chemistry and Biochemistry, University of North Carolina Greensboro, NC 27402, USA.

出版信息

Chem Phys Lipids. 2011 Feb;164(2):131-43. doi: 10.1016/j.chemphyslip.2010.12.003. Epub 2010 Dec 24.

Abstract

Both L-α-lysophosphatidylinositol (LPI) and 2-arachidonoyl-sn-glycero-3-phosphoinositol (2-AGPI) have been reported to activate the putative cannabinoid receptor, GPR55. Recent microsecond time-scale molecular dynamics (MD) simulations and isothiocyanate covalent labeling studies have suggested that a transmembrane helix 6/7 (TMH6/7) lipid pathway for ligand entry may be necessary for interaction with cannabinoid receptors. Because LPI and 2-AGPI are lipid-derived ligands, conformations that each assumes in the lipid bilayer are therefore likely important for their interaction with GPR55. We report here the results of 70 ns NAMD molecular dynamics (MD) simulations of LPI and of 2-AGPI in a fully hydrated bilayer of 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC). These simulations are compared with a 70 ns simulation of the cannabinoid CB1 receptor endogenous ligand, N-arachidonoylethanolamine (anandamide, AEA) in a POPC bilayer. These simulations revealed that (1) LPI and 2-AGPI sit much higher in the bilayer than AEA, with inositol headgroups that can at times be solvated completely by water; (2) the behavior of the acyl chains of AEA and 2-AGPI are similar in their flexibilities in the bilayer, while the acyl chain of LPI has reduced flexibility; and (3) both 2-AGPI and LPI can adopt a tilted headgroup orientation by hydrogen bonding to the phospholipid phosphate/glycerol groups or via intramolecular hydrogen bonding. This tilted head group conformation (which represents over 40% of the conformer population of LPI (42.2 ± 3.3%) and 2-AGPI (43.7 ± 1.4%)) may provide a low enough profile in the lipid bilayer for LPI and 2-AGPI to enter GPR55 via the putative TMH6/7 entry port.

摘要

L-α-溶血磷脂酰肌醇 (LPI) 和 2-花生四烯酰基-sn-甘油-3-磷酸肌醇 (2-AGPI) 均已被报道可激活假定的大麻素受体 GPR55。最近的微秒时间尺度分子动力学 (MD) 模拟和异硫氰酸酯共价标记研究表明,跨膜螺旋 6/7 (TMH6/7) 脂质途径对于配体进入可能是与大麻素受体相互作用所必需的。由于 LPI 和 2-AGPI 是脂衍生的配体,因此它们在脂质双层中假定的构象对于它们与 GPR55 的相互作用可能很重要。我们在此报告了 70 ns NAMD 分子动力学 (MD) 模拟 LPI 和 2-AGPI 在 1-棕榈酰-2-油酰-sn-甘油-3-磷酸胆碱 (POPC) 全水合双层中的结果。这些模拟与大麻素 CB1 受体内源性配体 N-花生四烯酰基乙醇胺 (花生四烯酸乙醇胺,AEA) 在 POPC 双层中的 70 ns 模拟进行了比较。这些模拟表明:(1) LPI 和 2-AGPI 位于双层中的位置比 AEA 高得多,其肌醇头部基团有时可以完全被水溶剂化;(2) AEA 和 2-AGPI 的酰链在双层中的柔韧性相似,而 LPI 的酰链柔韧性降低;(3) 2-AGPI 和 LPI 都可以通过与磷脂磷酸/甘油基团形成氢键或以分子内氢键的方式采用倾斜的头部基团取向。这种倾斜的头部基团构象(代表 LPI(42.2 ± 3.3%)和 2-AGPI(43.7 ± 1.4%)构象群体的 40%以上)可能为 LPI 和 2-AGPI 提供足够低的双层轮廓,使其通过假定的 TMH6/7 进入端口进入 GPR55。

相似文献

1
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55.
Chem Phys Lipids. 2011 Feb;164(2):131-43. doi: 10.1016/j.chemphyslip.2010.12.003. Epub 2010 Dec 24.
4
A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.
J Biol Chem. 2010 Jun 4;285(23):17954-64. doi: 10.1074/jbc.M109.041590. Epub 2010 Mar 10.
5
The endocannabinoids anandamide and virodhamine modulate the activity of the candidate cannabinoid receptor GPR55.
J Neuroimmune Pharmacol. 2012 Dec;7(4):856-65. doi: 10.1007/s11481-012-9351-6. Epub 2012 Mar 28.
7
The conformation, location, and dynamic properties of the endocannabinoid ligand anandamide in a membrane bilayer.
J Biol Chem. 2005 Aug 19;280(33):29788-95. doi: 10.1074/jbc.M502925200. Epub 2005 Jun 17.
9
The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
Prostaglandins Other Lipid Mediat. 2013 Dec;107:103-16. doi: 10.1016/j.prostaglandins.2013.05.004. Epub 2013 May 25.
10
What is the natural ligand of GPR55?
J Biochem. 2011 May;149(5):495-7. doi: 10.1093/jb/mvr022. Epub 2011 Feb 15.

引用本文的文献

1
Potential and Limits of Cannabinoids in Alzheimer's Disease Therapy.
Biology (Basel). 2021 Jun 17;10(6):542. doi: 10.3390/biology10060542.
2
Fingolimod: Lessons Learned and New Opportunities for Treating Multiple Sclerosis and Other Disorders.
Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:149-170. doi: 10.1146/annurev-pharmtox-010818-021358.
3
Molecular Dynamics Methodologies for Probing Cannabinoid Ligand/Receptor Interaction.
Methods Enzymol. 2017;593:449-490. doi: 10.1016/bs.mie.2017.05.004. Epub 2017 Jul 4.
4
Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
Biochemistry. 2017 Jan 24;56(3):473-486. doi: 10.1021/acs.biochem.6b01013. Epub 2017 Jan 11.
5
The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
Br J Pharmacol. 2015 Aug;172(16):4107-18. doi: 10.1111/bph.13196. Epub 2015 Jun 26.
6
Lysophospholipid receptor nomenclature review: IUPHAR Review 8.
Br J Pharmacol. 2014 Aug;171(15):3575-94. doi: 10.1111/bph.12678. Epub 2014 Jul 12.
8
Minireview: recent developments in the physiology and pathology of the lysophosphatidylinositol-sensitive receptor GPR55.
Mol Endocrinol. 2011 Nov;25(11):1835-48. doi: 10.1210/me.2011-1197. Epub 2011 Sep 29.

本文引用的文献

1
All-atom empirical potential for molecular modeling and dynamics studies of proteins.
J Phys Chem B. 1998 Apr 30;102(18):3586-616. doi: 10.1021/jp973084f.
2
A lipid pathway for ligand binding is necessary for a cannabinoid G protein-coupled receptor.
J Biol Chem. 2010 Jun 4;285(23):17954-64. doi: 10.1074/jbc.M109.041590. Epub 2010 Mar 10.
3
The putative cannabinoid receptor GPR55 affects osteoclast function in vitro and bone mass in vivo.
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16511-6. doi: 10.1073/pnas.0902743106. Epub 2009 Sep 3.
4
Atypical responsiveness of the orphan receptor GPR55 to cannabinoid ligands.
J Biol Chem. 2009 Oct 23;284(43):29817-27. doi: 10.1074/jbc.M109.050187. Epub 2009 Sep 1.
6
2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.
J Biochem. 2009 Jan;145(1):13-20. doi: 10.1093/jb/mvn136. Epub 2008 Oct 9.
7
The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
FASEB J. 2009 Jan;23(1):183-93. doi: 10.1096/fj.08-108670. Epub 2008 Aug 29.
9
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.
Proc Natl Acad Sci U S A. 2008 Feb 19;105(7):2699-704. doi: 10.1073/pnas.0711278105. Epub 2008 Feb 8.
10
The orphan receptor GPR55 is a novel cannabinoid receptor.
Br J Pharmacol. 2007 Dec;152(7):1092-101. doi: 10.1038/sj.bjp.0707460. Epub 2007 Sep 17.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验